China Pharma Holdings (CPHI) Net Margin Growth (1y) (2011 - 2026)

China Pharma Holdings (CPHI) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 372.00
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -82.00
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -538.00
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -2,930.00
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 2,292.00
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -146.00
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1,181.00
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -2,359.00
10 China Pharma Holdings 19.13 Mn 18.97 Mn 285,487.00 -4,709.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -4,709.00
Dec 31, 2025 829.00
Sep 30, 2025 1,546.00
Jun 30, 2025 10,397.00
Mar 31, 2025 65.00
Dec 31, 2024 -5,065.00
Sep 30, 2024 -5,850.00
Jun 30, 2024 -10,147.00
Mar 31, 2024 -4,550.00
Dec 31, 2023 -1,404.00
Sep 30, 2023 -289.00
Jun 30, 2023 106.00
Mar 31, 2023 3,990.00
Dec 31, 2022 -934.00
Sep 30, 2022 156.00
Jun 30, 2022 -2,093.00
Mar 31, 2022 -3,165.00
Dec 31, 2021 731.00
Sep 30, 2021 29.00
Jun 30, 2021 -3,449.00